Core Viewpoint - B. Riley analyst John Massocca has raised the price target for Diversified Healthcare Trust (DHC) to $8.50 from $6.50, maintaining a Buy rating on the shares, indicating a positive outlook for the company's growth potential in 2026 [1] Summary by Category Price Target Adjustment - The price target for DHC has been increased to $8.50 from $6.50 [1] Analyst Rating - B. Riley maintains a Buy rating on DHC shares, reflecting confidence in the company's performance [1] Growth Potential - The firm's analysis suggests that DHC's 2026 outlook indicates significant "value growth potential" [1] - The stock is viewed as being discounted too severely compared to its peers [1]